Sinopharm Group 

€11.3
44
+€0+0% Thursday 08:41

统计数据

当日最高
11.5
当日最低
11.3
52周最高
-
52周最低
-
成交量
200
平均成交量
-
市值
7.36B
市盈率
6.48
股息收益率
5.05%
股息
0.57

即将到来

股息

5.05%股息收益率
10年增长
13.69%
5年增长
8.54%
3年增长
8.65%
1年增长
8.68%

收益

25Aug预期
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0.69
1.04
1.4
1.75
预期每股收益
1.4800067469359999
实际每股收益
1.2762377020679998

人们还关注

此列表基于关注X2S1.F的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Show more...
首席执行官
Mr. Wanyong Lian
员工
113635
国家
US
ISIN
US82937K1016
WKN
000A2P3LX

上市公司